Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
Al-Alem L, Prendergast JM, Clark J, Zarrella B, Zarrella DT, Hill SJ, Growdon WB, Pooladanda V, Spriggs DR, Cramer D, Elias KM, Nazer RI, Skates SJ, Behrens J, Dransfield DT, Rueda BR.
Al-Alem L, et al. Among authors: nazer ri.
J Ovarian Res. 2024 Apr 2;17(1):71. doi: 10.1186/s13048-024-01397-1.
J Ovarian Res. 2024.
PMID: 38566237
Free PMC article.